Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.42 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.38 |
| ▸ | STS | P08842 | 2/20 | 0.37 |
| ▸ | KDM1A | O60341 | 2/20 | 0.37 |
| ▸ | NAMPT | P43490 | 1/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | TERT | O14746 | 1/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.35 |
| ▸ | PREP | P48147 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29987921 | 0.88 | GPR119 (0.44) | CHRM2CHRM1CHRM3GPR119KDM4E | |
| SCHEMBL29987914 | 0.88 | GPR119 (0.44) | CHRM2CHRM1CHRM3GPR119KDM4E | |
| SCHEMBL29987993 | 0.88 | GPR119 (0.44) | CHRM2CHRM1CHRM3GPR119KDM4E | |
| SCHEMBL13137753 | 0.87 | GPR119 (0.47) | CHRM2CHRM1CHRM3GPR119KDM4E | |
| Hydrochloric Acid SCHEMBL30041068 | 0.86 | GPR119 (0.46) | CHRM2CHRM1CHRM3GPR119KDM4E | |
| SCHEMBL29987990 | 0.85 | GPR119 (0.40) | CHRM2CHRM1CHRM3GPR119KDM4E | |
| SCHEMBL23611614 | 0.84 | CHRM2 (0.40) | CHRM2CHRM1CHRM3GPR119KDM4E | |
| SCHEMBL23611599 | 0.78 | FFAR2 (0.37) | — | |
| SCHEMBL23611561 | 0.77 | DDB1 (0.41) | CHRM2CHRM1CHRM3GPR119KDM4E | |
| SCHEMBL29987892 | 0.76 | GPR119 (0.39) | CHRM2CHRM1CHRM3GPR119KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118324762-A | Compounds and compositions for treating CNS disorders | 布鲁奥科制药有限公司 | 2024-07-12 | — | — | CN | disclosed |
| US-20230116114-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS | BLUE OAK PHARMACEUTICALS, INC. | 2023-04-13 | — | — | US | disclosed |
| EP-4084797-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS | Blue Oak Pharmaceuticals, Inc. (US) | 2022-11-09 | — | — | EP | disclosed |
| WO-2021138314-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS | BLUE OAK PHARMACEUTICALS, INC. (US) | 2021-07-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230116114-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS | PMP22, CHAT, ACHE | CHRM2 141/4885CHRM1 330/4885CHRM3 97/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.